the AYA Movement in the US Today Current State and the Way Forward Karen Albritton MD Simon Davies February 16 2019 That all AYAs in US have access to and delivery of biologically based developmentally appropriate evidenceinformed ID: 811097
Download The PPT/PDF document "AYA Oncology Programs and" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
AYA Oncology Programs and the AYA Movement in the US Today: Current State andthe Way Forward
Karen Albritton, MDSimon DaviesFebruary 16, 2019
Slide2That all AYAs in US have access to and delivery of biologically based, developmentally appropriate, evidence-informed care in age appropriate settings (from prevention, early detection, treatment through survivorship) that provides best survival and maintenance of QOL during and after cancerThe Vision
Slide3Research - epi, health services, biology and clinical interventionsStandards - with metrics and accountabilityProvider educationPatient support (including age-appropriate environments)Community awareness
What Domains are required
Slide42004 COG AYA committee 2005-6 Progress Review Group2006 SEER monograph on AYA oncology (15-29)2006-7 Livestrong Young Adult Alliance5 year implementation plan2008 HOPE study begins
AYA Movement History in U.S.
Slide52009-10 LSYAA Quality Cancer Care position statement from Std of Care task Force2009 NCI/LAF Biology Workshop2011 Society of AYA Oncology forms2012 Report of LSYAA Implementation Plan
AYA Movement History in U.S.
Slide62012 – Critical Mass satellites from LAFOrganizational membership2012 NCCN Guidelines for AYA CancerChange it Back Centers of Excellence2013 Teen Cancer America
2013 JAYAO 2013 NCI “Next Steps” – a scientific update
AYA Movement History in U.S.
Slide72016 SWOG AYA committee2016 Critical Mass shifts to advocacy2017 Global Congress held in Atlanta12/18 Critical Mass shuts down
AYA Movement History in U.S.
Slide8WHERE WE ARE TODAY
Slide9PROGRAMS23 AYA Programs invested in by TCA17 academic/6 community11 ped-led/3 adult-led/9 partnership2 independently managed hospitals collaborating
5 more due in March 87 hospitals consulting TCA
Slide10RESEARCH
COG AYA committee
SWOG AYA committee
NCTN with AYA trials
NCI
Healthcare Delivery Research Program
SEER
National AYA Research Strategy meetings
National Registry for AYA
Clinical Trial access for all AYA’s
Biorepository
Standard AYA measures (distress thermometer, QOL)
Priority setting body
Investment in AYA research
WHAT WE HAVE
WHAT WE LACK
WHAT WE COULD BORROW/STEAL
WHAT WE MIGHT USE
National AYA Research Strategy Group
CAYACC
NCORP
Childhood Cancer Survivorship Survey
National Cancer Research AYA Clinical Studies Group
Slide11STANDARDSLivestrong Quality Cancer Care position statement
NCCN AYA (supportive care) Guidelines
Change it Back Center of Excellence criteria Teen Cancer America Strategic Guidelines for developing programs
No accountability organization, accrediting body
Agreement on mandate to refer to “center of excellence”
Self-assessment OR benchmarking tool
WHAT WE HAVE
WHAT WE LACK
WHAT WE COULD BORROW/STEAL
WHAT WE MIGHT USE
NICE Guidlelines/NHS Service specifications
Teenage Cancer Trust ‘A blueprint of care for teenagers and young adults with cancer.’
CanTeen and Cancer Australia: ‘The National Service Delivery Framework for Adolescents and Young Adults with Cancer’.
New Zealand Service Provisions/Standards of Care
Canadian Task Force on Adolescents and Young Adults (AYA) with cancer framework of care.
American College of Surgeons COC accreditation
Slide12PROVIDER EDUCATION
2010 JCO position statement of essential elements of provider education
Early Fellowships – eg. Cincinnati, USC
Global AYA Cancer Congress
Regional conferences
Teen Cancer America Monthly Drip
JAYAO
National Conference
National AYA accredited training in the professions
WHAT WE HAVE
WHAT WE LACK
WHAT WE COULD BORROW/STEAL
WHAT WE MIGHT USE
Other professional organizations:
ASCO, ONS, ASPHO, APHON, APOS, AONN
Coventry Nursing Program
TYAC
TCT and Royal College of Nursing “Competencies :Caring for Teenagers and Young Adults with Cancer: A Competence and Career Framework for Nursing”
Slide13PATIENT SUPPORT
Teen Cancer America supported programs
Teen Cancer America AYA Rooms/Zones
Stupid Cancer/Cancer Con
Regional Conferences
Imermans Angels
Livestrong
First Descents
Lacuna Loft
Ulman Fund - Mission Control
NCCN AYA Guidebook
Regional charities eg. FWAYA, Ried R Sacco, Be Loud for Sophie
Coordinated advocacy
Representation on Capitol Hill
Comprehensive handbook/one stop website
WHAT WE HAVE
WHAT WE LACK
WHAT WE COULD BORROW/STEAL
WHAT WE MIGHT USE
American Cancer Society
Cancer Support Community
Find Your Sense of Tumor
Canteen “Now What”?
Slide14PUBLIC AWARENESS
15-40 Coalition
Teen Cancer America (Cancer Rebellion)
Many regional initiatives
Enough celebrity attention
National AYA Fundraising Activity
Media platform
WHAT WE HAVE
WHAT WE LACK
WHAT WE COULD BORROW/STEAL
WHAT WE MIGHT USE
National AYA week
Pharma and other corporate support
Canteen Bandana campaign
Slide15Large number of AYAs (75,000)UK (2100) (15-24)Australia (less than 1000) (15-30)Canada (7600) (15-39)Most of AYAs treated in community hospitalsHealth Insurance restrictions
Lack of nationally coordinated health service Little enforcement/auditing of standards of careLimited financing to date (either gov’t or philanthropic)
Competition hindering collaboration
Lack of networked care in cities and regions
Particular US challenges
Slide16An AYA leadershipA professional membership organization (ala TYAC)- SAYAO?Provider educationBest practice guidelinesCredentialing
? Accreditation of centers of excellenceA research cooperative groupA patient support organization (ala Canteen/TCT)- TCA?Also responsible for raising awareness
What infrastructure is needed?
Slide17National AYA Cancer Field
Slide18We owe it to them!
Slide19NEXT STEPS?What is needed. Discussion?
Slide20RESOURCE SLIDES
Slide21…we hope to raise awareness of the need for evidence-based guidelines for AYA care and, in the interim before development of those guidelines, assist NCI-designated cancer centers, community cancer centers and hospitals, and private oncology practices in delivering optimal quality cancer care for AYAs. This position statement reflects distinct needs related to the diagnosis, treatment, and care of AYAs with cancer, as suggested by emergent research and clinical observations.2009 Livestrong YAA Quality Cancer Care position statement
Slide22NCCN guidelinesThe goal of the NCCN Guidelines for AYA Oncology is to identify issues specific to the AYA population, recommend interventions unique to the AYA population; education physicians regarding the prevalence of cancer in AYAs; discuss long-term consequences; explain special considerations related to cancer management in AYA patients that aim to improve treatment tolerance, compliance and clinical outcomes; and promote participation in clinical trials.
Slide23Treatment related issuesSite of careClinical trialsDose schedulesManagement of Toxicities Adherence
Fertility and Reproductive endocrine considerationsPsychosocial considerations- including individual behavioral factors, relationships, socioeconomic issues
Survivorship- late effects and long term followupDisease specific issues related to age
Palliative and End-of-life care
NCCN Guidelines
Slide24https://www.ayacancernetwork.org.nz.
Slide25The goal of the standards is to achieve excellence in AYA cancer care and address outcome disparities for certain ethnic, disease specific and age related populations for and among AYA in New Zealand. The standards will drive measurable quality improvements for this age group by enabling:Health professionals to make decisions about care based on the latest evidence and best practice. Young people receiving health and supportive care services, their whānau and carers and the public to find information about the quality of services and care they should expect from their providers. Service providers to quickly and easily examine the performance of their organisation and assess improvement in standards of care they provide.
Funders to be confident that the services they are purchasing are high quality and cost effective and focused on driving up quality.
New Zealand
Slide26A national framework is necessary to ensure consistent and cohesive care is provided to the relatively small numbers of AYAs diagnosed with cancer who are widely spread across the country. The AYA Cancer Network Aotearoa is responsible for the clinical oversight and leadership of these standards of care, including development and ongoing monitoring and evaluation. The Network has developed an online self-review tool to support these standards. The tool is designed to help service providers understand what aspects of the support and care they provide to AYAs in their region is working well and to identify areas where service improvements are required. The tool encourages sector-wide collaboration and the development of local service development plans that link with the national strategy for AYA cancer care. It is not intended to be a compliance tool for bench marking or making regional comparisons.
Slide27…created under the auspices of the SA Cancer Clinical Network. It provides recommendations based on current evidence for best practice in the management of adolescents and young adults aged 15–25 years with a cancer diagnosis. …developed through a collaborative effort involving a wide range of health professionals, including paediatric and adult cancer specialists, generalist staff and consumers. It is a statement of consensus based on current best practice, evidence and accepted approaches to the management of adolescents and young adults throughout their cancer journey. South Australian (SA) Adolescent and Young Adult Cancer Care Pathway
Slide28Improve cancer outcomes for adolescents and young adults by fully applying each BRP recommendation to this population; foster clinical trial networks specifically for clinical and biological research of cancers in adolescents and young adults, and identify effective cancer care delivery modelsMeasure: Increase research into cancers in adolescents and young adults, and increase access to clinical trialsMetric: Increase proportion of adolescent and young adult patients with cancer who are treated at large centres (4 years)
Adolescent and young adult oncology—Adolescents and young adults with cancer are a vulnerable subpopulation whose outcomes have not improved to the same extent as those of young children.160 The cancers in adolescents and young adults are different to those of children and older adults because they represent a transition period between paediatric-like, embryonal cancers derived from mesodermal tissues and adult-like carcinomas derived from epithelial tissues. The most common cancers in this age range (eg, Hodgkin’s disease, germ-cell tumours, thyroid cancer, sarcomas) are rare compared with the more common cancers in adults.161 More than 90% of adolescents and young adults in North America receive their care in community practices where expertise in treating cancers in adolescents and young adults might be limited.162,163 Because most community practices do not participate in the US National Cancer Institute’s National Clinical Trial Network, this subpopulation has not benefited from the standardisation of care, the incremental improvement of sequential clinical trials, or the insights derived from linking biospecimens to clinical outcomes. Many other possible mechanisms could explain the survival gap in this group of patients, such as unfavourable tumour biology, unique pharmacokinetics, diagnostic delay, and poor adherence to prescribed therapies.165–168
If fully applied to adolescents and young adults, the BRP recommendations will revolutionise oncology for these patients. For example, the BRP recommendation to develop a federated network of tumour profiling services accessible to patients and linked with opportunities for clinical trial participation could have a particularly important and positive effect on these patients.
In addition to existing BRP recommendations, two major recommendations specific to cancer treatment for adolescents and young adults are warranted. First, a clinical trial network specific to this subpopulation should be developed to encourage the development and reach of clinical trials specifically designed for this age group. This network could be independent, but would ideally represent collaborative efforts between adult and paediatric groups. The success of such trials has already been demonstrated. Investigators in both the Dana-Farber Cancer Institute ALL Consortium169 and the US Intergroup study C10403170 examined the use of paediatric-style ALL treatment protocols in adolescents and young adults and found markedly increased survival compared with traditional adult protocol-based treatment. Second, research on the most effective health-care delivery model for adolescents and young adults with cancer is essential. Despite the evidence outlined above, investigators in California found that the percentage of adolescents and young adults with ALL receiving appropriate treatment actually decreased from 31% in 2008–12 to 21% in 2013–14.163 According to findings from the population-based AYA-HOPE study,171 nearly 30% of adolescents and young adults across settings did not receive appropriate medical therapy. Several jurisdictions have built alternative models of cancer care delivery for this age group; for example, the UK has built a nationwide network of cancer units for adolescents and young adults.172 Although the BRP denotes issues such as coverage and fragmentation of care delivery as beyond the scope of their report, an assessment of these novel, mature mechanisms of cancer care delivery would inform future initiatives for adolescents and young adults. Goals should include improving cancer outcomes by fully applying each BRP recommendation to this population, fostering a clinical trial network for clinical and biological research that is specifically for adolescents and young adults, and identifying effective cancer care delivery models for this age group.
Lancet Oncology
Commission on Future cancer research priorities (followup on Blue Ribbon Panel)
Slide29Slide30Slide31[
UK]
National Institute of Clinical and Health Excellence publishes Guidance report for improving outcomes in children and YAs (13-25)
[
UK
]
TYA Cancer Clinical Studies group established
[
AUS
]
1985 – 6 teenagers start CanTeen for peer support (12-25)
[
CANADA
]
CPAC/C17 establish Task Force on AYAs with Cancer to improve oncology care (12-29)
[
AUS
]
Federal gov’t funds Youth Cancer Networks Program with $15 million to be matched by regions
[
UK
]
1990 – First specialist unit built by Teenage Cancer Trust
Slide32[
UK] National Cancer Intelligence Network connects all cancer intelligence data recording and collection. By 2014, available in real time
[
UK
]
All designated Cancer Centers required to adhere to national standards of care and treatment
[
CAN
]
Diploma program in AYA oncology developed
[
AUS
]
Federal gov’t gives Youth Cancer Services additional $18.2 million over 4 years for research and specialized services